Navigation Links
WuXi PharmaTech Announces Second-Quarter 2012 Results
Date:8/13/2012

nagement and investors benefit from referring to these non-GAAP financial measures in assessing our financial performance and liquidity and when planning and forecasting future periods. These non-GAAP operating measures are useful for understanding and assessing underlying business performance and operating trends. We expect to continue to provide net income and earnings per ADS on a non-GAAP basis using a consistent method on a quarterly basis.

You should not view non-GAAP results on a stand-alone basis or as a substitute for results under GAAP, or as being comparable to results reported or forecasted by other companies, and should refer to the reconciliation of GAAP measures to non-GAAP measures for the indicated periods attached hereto.

Statements in this release contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, and as defined in the Private Securities Litigation Reform Act of 1995, including, among others, our financial guidance for full-year and third-quarter 2012 (including, as applicable, estimated total revenues, Laboratory Services revenues, Manufacturing Services revenues, operating margins and other trends), pharmaceutical research and development outsourcing trends, our ability to take advantage of increasing pharmaceutical research and development outsourcing, increased customer demand for our services, investment in various new businesses, investment in expanding our existing business, building a comprehensive and integrated technology platform, the ability of this platform to enable anyone and any company to discover and develop new products efficiently and cost-effectively, and our share repurchase program.

These forward-looking statements are not historical facts but instead represent only our belief regarding future events, many of which, by their nature, are inherently uncertain and outside o
'/>"/>

SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine technology :

1. Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
2. WuXi PharmaTech Announces First-Quarter 2012 Results
3. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
4. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
5. Varian Medical Systems CEO Timothy E. Guertin Announces Plans to Retire; Board of Directors Names Dow R. Wilson as Successor
6. Comprehensive Care Corporation Announces Profitable Six Month Financial Results
7. Tactical Medical Packs Announces New Disaster Medical Packs Equipping First Responders for Mass Casualty Incidents
8. Echo Therapeutics Announces Second Quarter 2012 Financial Results
9. Bacterin International Announces Second Quarter and Six Months 2012 Financial Results
10. Arena Pharmaceuticals Announces Second Quarter 2012 Financial Results and Recent Developments
11. 3SBio Inc. Announces Changes to Its Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 UBM Medica US ... a new online community and information resource for neurologists ... and treat their patients with neurological disorders . ... an aging population, necessitates greater access to dedicated information ... statistics on neurological conditions include: , 1 ...
(Date:7/23/2014)... July 23, 2014 Research and Markets ... (ECG) Market by Product, End-user & by Lead Type ... offering. http://photos.prnewswire.com/prnh/20130307/600769 ... into three major segments, namely, holter monitor, resting, and ... valued at $3,683 million in 2013 and is poised ...
(Date:7/23/2014)... -- The Centers for Medicare & Medicaid Services (CMS) ... Organization (QIN-QIO) contract to a partnership led by the ... 1, WVMI will launch Quality Insights Quality Innovation Network ... Pennsylvania , Delaware , ... will engage providers and the community in multiple, data-driven ...
Breaking Medicine Technology:UBM Medica US Launches NeurologyTimes.com 2UBM Medica US Launches NeurologyTimes.com 3Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 2Global Diagnostic Electrocardiograph (Resting, Stress, Holter Monitor) (ECG) Market - Forecast to 2020 3Announcing a New Regional Approach to Medicare Quality Improvement 2
... June 29 Max Neeman International, India ,s ... extended the platform to provide expert CDISC (Clinical Data Interchange Standards ... data conversion, implementation of CDISC standards and CDISC compliance checks. , ... CDISC SDTM (Standard ...
... IRVINE, Calif. , June 29 Avrio Biopharmaceuticals, ... of David A. Gelber as the Director of Manufacturing. ... production systems and ensuring clients receive high quality service in a ... , ...
Cached Medicine Technology:Max Neeman International Expands Data Management Services with Conversion Into CDISC Standard Data Model 2Avrio Appoints David L. Gelber to Director of Manufacturing 2Avrio Appoints David L. Gelber to Director of Manufacturing 3
(Date:7/23/2014)... HealthDay Reporter WEDNESDAY, July ... may not be as effective against cystic fibrosis as ... that one of the medications might stop the other ... definitive, and there,s still hope for the medications known ... the study,s senior author. "The development of drugs ...
(Date:7/23/2014)... The next episode of “Extreme Weight ... who was physically fit through childhood and adolescence. After ... the heart-wrenching decision to give her son up for ... 18 years, and she punished herself by overeating, gaining ... unique, non-competitive approach to weight loss transformations, “Extreme Weight ...
(Date:7/23/2014)... Inventor and entrepreneur Delegate Joe T. ... the gas pump – sharing his passion for technology ... at Noon. , With 24 patents granted and three ... anyone in the General Assembly since Thomas Jefferson. Inventions ... marker as seen on television, an instrument for measuring ...
(Date:7/23/2014)... A new study supports a growing body of ... natural steroid hormones in treating postmenopausal breast cancer, ... profile than with standard anti-hormone therapies. The study ... the open-access journal Reproductive Biology and Endocrinology ... diagnosed cancer in women in the United States. ...
(Date:7/23/2014)... FL (PRWEB) July 23, 2014 Rich Dad® ... the success of their charity yard sale to support Habit ... raised and 100% of the proceeds will be donated to ... the event are being donated to the Habitat for Humanity ... Myers, Florida 33903. , One of the highlights of ...
Breaking Medicine News(10 mins):Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 2Health News:Cystic Fibrosis Drug Combo May Be Less Effective Than Hoped 3Health News:“Extreme Weight Loss”: Cassie’s journey begins at the University of Colorado Anschutz Health and Wellness Center 2Health News:Celebrating Innovation and Invention 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 2Health News:Hormones after breast cancer: Not fuel for the fire after all? 3Health News:Hormones after breast cancer: Not fuel for the fire after all? 4Health News:Hormones after breast cancer: Not fuel for the fire after all? 5Health News:Rich Dad Education Charity Yard Sale Raises Over $650 for Habitat for Humanity of Lee and Hendry Counties 2
... , THURSDAY, Feb. 23 (HealthDay News) Compared ... of death in elderly patients with dementia, a new ... should aid in dementia care. "This data provides much-needed ... care practitioners treating older demented patients," said Dr. Gisele ...
... HealthDay Reporter , THURSDAY, Feb. 23 (HealthDay News) ... those known to be infected, actually struck many more people ... finds. The actual fatality rate of the H5N1 flu ... millions of people may have been infected over the past ...
... , THURSDAY, Feb. 23 (HealthDay News) -- ... treat children with attention-deficit hyperactivity disorder (ADHD) and other ... study shows. Researchers analyzed data from more than ... assess the use of psychiatric medications in those with ...
... 23 (HealthDay News) -- Noninvasive, CT-guided "virtual" colonoscopy is ... colorectal cancer and precancerous polyps in people 65 and ... called CT colonography, uses virtual-reality technology to produce 3-D ... by many patients, its effectiveness in comparison with invasive ...
... , THURSDAY, Feb. 23 (HealthDay News) -- ... and emergency department visits, improved patient outcomes and saved ... study. Researchers examined the impact of the Community ... families, developed and implemented in 2005 by a team ...
... compound that in laboratory tests blocks inflammation-causing molecules ... cancer and cardiovascular disease without causing harmful toxicity. ... compounds that tamp down so-called reactive oxygen species ... toxicity issues and a lack of specificity in ...
Cached Medicine News:Health News:Certain Antipsychotics Up Risk of Death for Patients With Dementia: Study 2Health News:'Bird' Flu May Be More Common in Humans, But Less Deadly 2Health News:Meds for Autism Not Well Understood: Study 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 2Health News:Study Supports CT-Based 'Virtual' Colonoscopy to Spot Colon Cancer 3Health News:Home-Visit Program May Improve Child's Asthma 2Health News:New class of compounds stops disease-fueling inflammation in lab tests 2Health News:New class of compounds stops disease-fueling inflammation in lab tests 3
e-MDs Bill practice management system is used in the medical billing cycle....
Protologics Corporation announces ProtoCLAIMS, Web-based electronic claims product that links and reconciles desktop claims with insurance payers who offer direct claims processing....
Visionary OFFICE™ PM offers a Windows interface featuring medical billing, appointment scheduling and patient information....
... system allows a practice to manage ... integrated with the EMR, appointment system ... with electronic clearinghouses for electronic claim ... of reports, it presents practice management ...
Medicine Products: